Jacqueline Ramı́rez

5.0k total citations · 2 hit papers
77 papers, 3.8k citations indexed

About

Jacqueline Ramı́rez is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, Jacqueline Ramı́rez has authored 77 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Molecular Biology, 42 papers in Oncology and 24 papers in Pharmacology. Recurrent topics in Jacqueline Ramı́rez's work include Cancer therapeutics and mechanisms (35 papers), Pharmacogenetics and Drug Metabolism (23 papers) and Lung Cancer Research Studies (13 papers). Jacqueline Ramı́rez is often cited by papers focused on Cancer therapeutics and mechanisms (35 papers), Pharmacogenetics and Drug Metabolism (23 papers) and Lung Cancer Research Studies (13 papers). Jacqueline Ramı́rez collaborates with scholars based in United States, China and Germany. Jacqueline Ramı́rez's co-authors include Mark J. Ratain, Federico Innocenti, Lalitha Iyer, Soma Das, Linda Janisch, Everett E. Vokes, Samir D. Undevia, Gini F. Fleming, Theodore Karrison and Charles M. Rudin and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Blood.

In The Last Decade

Jacqueline Ramı́rez

74 papers receiving 3.8k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Genetic Variants in the UDP-glucuronosyltransferase 1A1 Gene Predict the Risk of Severe Neutropenia of Irinotecan

2004 695 citations Federico Innocenti, Samir D. Undevia et al. Journal of Clinical Oncology profile →
UGT1A1*28 polymorphism as a determinant of irinotecan disposition and toxicity

2002 521 citations Linda Janisch, Jacqueline Ramı́rez et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Jacqueline Ramı́rez	2.1k	2.1k	926	659	451	77	3.8k
Lalitha Iyer	2.4k 1.1×	1.7k 0.8×	723 0.8×	598 0.9×	294 0.7×	52	4.0k
Balram Chowbay	1.4k 0.7×	1.7k 0.8×	1.3k 1.4×	611 0.9×	514 1.1×	109	4.2k
Masato Chiba	1.1k 0.5×	1.7k 0.8×	1.2k 1.3×	519 0.8×	689 1.5×	114	3.7k
Laurent P. Rivory	2.0k 0.9×	2.2k 1.0×	739 0.8×	319 0.5×	407 0.9×	96	4.0k
Andrew Rowland	1.5k 0.7×	2.4k 1.1×	1.4k 1.5×	466 0.7×	732 1.6×	144	4.9k
Éric Lévesque	1.4k 0.7×	721 0.3×	1.3k 1.4×	478 0.7×	498 1.1×	101	3.1k
Philip C. Smith	1.1k 0.5×	942 0.5×	1.4k 1.5×	433 0.7×	314 0.7×	120	3.6k
Gareth J. Veal	1.3k 0.6×	1.0k 0.5×	244 0.3×	615 0.9×	570 1.3×	136	3.7k
Csilla Özvegy‐Laczka	1.3k 0.6×	2.5k 1.2×	350 0.4×	618 0.9×	234 0.5×	71	3.4k
Jan Snoeys	1.2k 0.6×	897 0.4×	906 1.0×	451 0.7×	141 0.3×	94	3.7k

Countries citing papers authored by Jacqueline Ramı́rez

Since Specialization

Citations

This map shows the geographic impact of Jacqueline Ramı́rez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacqueline Ramı́rez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacqueline Ramı́rez more than expected).

Fields of papers citing papers by Jacqueline Ramı́rez

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacqueline Ramı́rez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacqueline Ramı́rez. The network helps show where Jacqueline Ramı́rez may publish in the future.

Co-authorship network of co-authors of Jacqueline Ramı́rez

This figure shows the co-authorship network connecting the top 25 collaborators of Jacqueline Ramı́rez. A scholar is included among the top collaborators of Jacqueline Ramı́rez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jacqueline Ramı́rez. Jacqueline Ramı́rez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Haudiquet, Matthieu, Zhiying Zhang, Jacqueline Ramı́rez, et al.. (2025). Structural basis for Lamassu-based antiviral immunity and its evolution from DNA repair machinery. Proceedings of the National Academy of Sciences. 122(47). e2519643122–e2519643122.

Nathan, Sally, et al.. (2023). The use of arts‐based methodologies and methods with young people with complex psychosocial needs: A systematic narrative review. Health Expectations. 26(2). 795–805. 24 indexed citations

Etheridge, Amy S., Eleftheria Tsakalozou, Jacqueline Ramı́rez, et al.. (2020). Optimal Sampling Strategies for Irinotecan (CPT-11) and its Active Metabolite (SN-38) in Cancer Patients. The AAPS Journal. 22(3). 59–59. 4 indexed citations

House, Larry, Michael J. Seminerio, Snezana Mirkov, et al.. (2017). Metabolism of megestrol acetate in vitro and the role of oxidative metabolites. Xenobiotica. 48(10). 973–983. 5 indexed citations

Pericay, Carles, Nieves Martínez Lago, Ismael Macías, et al.. (2016). P-051 Preliminary clinical and pathologic characteristics of patients treated in second-line (2L) with 25 cycles (Cy) or more of FOLFIRI + Aflibercept (FA). Annals of Oncology. 27. ii15–ii15. 1 indexed citations

Wu, Kehua, Larry House, Jacqueline Ramı́rez, Michael J. Seminerio, & Mark J. Ratain. (2013). Evaluation of Utility of Pharmacokinetic Studies in Phase I Trials of Two Oncology Drugs. Clinical Cancer Research. 19(21). 6039–6043. 5 indexed citations

Ramı́rez, Jacqueline, Tae Won Kim, Wanqing Liu, et al.. (2013). A pharmacogenetic study of aldehyde oxidase I in patients treated with XK469. Pharmacogenetics and Genomics. 24(2). 129–132. 9 indexed citations

Cohen, Ezra E.W., Kehua Wu, Christine Hartford, et al.. (2012). Phase I Studies of Sirolimus Alone or in Combination with Pharmacokinetic Modulators in Advanced Cancer Patients. Clinical Cancer Research. 18(17). 4785–4793. 51 indexed citations

Liu, Wanqing, Lijun He, Jacqueline Ramı́rez, et al.. (2011). Functional EGFR Germline Polymorphisms May Confer Risk for EGFR Somatic Mutations in Non–Small Cell Lung Cancer, with a Predominant Effect on Exon 19 Microdeletions. Cancer Research. 71(7). 2423–2427. 36 indexed citations

10.

Innocenti, Federico, Gregory M. Cooper, Ian B. Stanaway, et al.. (2011). Identification, Replication, and Functional Fine-Mapping of Expression Quantitative Trait Loci in Primary Human Liver Tissue. PLoS Genetics. 7(5). e1002078–e1002078. 134 indexed citations

11.

Liu, Yong, Jacqueline Ramı́rez, & Mark J. Ratain. (2011). Inhibition of paracetamol glucuronidation by tyrosine kinase inhibitors. British Journal of Clinical Pharmacology. 71(6). 917–920. 54 indexed citations

12.

Ramı́rez, Jacqueline, Kehua Wu, Linda Janisch, et al.. (2011). The effect of thalidomide on the pharmacokinetics of irinotecan and metabolites in advanced solid tumor patients. Cancer Chemotherapy and Pharmacology. 68(6). 1629–1632. 6 indexed citations

13.

Kamdem, Landry K., Yong Liu, Vered Stearns, et al.. (2010). In vitro and in vivo oxidative metabolism and glucuronidation of anastrozole. British Journal of Clinical Pharmacology. 70(6). 854–869. 60 indexed citations

14.

Liu, Wanqing, Lijun He, Jacqueline Ramı́rez, & Mark J. Ratain. (2009). Interactions between MDM2 and TP53 Genetic Alterations, and Their Impact on Response to MDM2 Inhibitors and Other Chemotherapeutic Drugs in Cancer Cells. Clinical Cancer Research. 15(24). 7602–7607. 15 indexed citations

15.

Innocenti, Federico, Deanna L. Kroetz, Erin G. Schuetz, et al.. (2009). Comprehensive Pharmacogenetic Analysis of Irinotecan Neutropenia and Pharmacokinetics. Journal of Clinical Oncology. 27(16). 2604–2614. 200 indexed citations

16.

Innocenti, Federico, Wanqing Liu, Donna L. Fackenthal, et al.. (2008). Single nucleotide polymorphism discovery and functional assessment of variation in the UDP-glucuronosyltransferase 2B7 gene. Pharmacogenetics and Genomics. 18(8). 683–697. 72 indexed citations

17.

Ramı́rez, Jacqueline, et al.. (2007). UGT1A1*28 genotype affects the in-vitro glucuronidation of thyroxine in human livers. Pharmacogenetics and Genomics. 17(8). 619–627. 23 indexed citations

18.

Yong, Wei Peng, Apurva A. Desai, Federico Innocenti, et al.. (2007). Pharmacokinetic modulation of oral etoposide by ketoconazole in patients with advanced cancer. Cancer Chemotherapy and Pharmacology. 60(6). 811–819. 18 indexed citations

19.

Ramı́rez, Jacqueline, Bernard J. Komoroski, Snezana Mirkov, et al.. (2006). Study of the genetic determinants of UGT1A1 inducibility by phenobarbital in cultured human hepatocytes. Pharmacogenetics and Genomics. 16(2). 79–86. 18 indexed citations

20.

Venook, Alan P., Colin Klein, Gini F. Fleming, et al.. (2003). A phase I and pharmacokinetic study of irinotecan in patients with hepatic or renal dysfunction or with prior pelvic radiation: CALGB 9863. Annals of Oncology. 14(12). 1783–1790. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact